Last Updated: May 10, 2026

Profile for Slovenia Patent: 1912999


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 1912999

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,148,399 Sep 5, 2029 Janssen Prods OLYSIO simeprevir sodium
8,349,869 Jul 28, 2026 Janssen Prods OLYSIO simeprevir sodium
8,741,926 Jul 28, 2026 Janssen Prods OLYSIO simeprevir sodium
8,754,106 Jul 28, 2026 Janssen Prods OLYSIO simeprevir sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent SI1912999: Scope, Claims, and Patent Landscape Analysis

Last updated: March 7, 2026

What is the Scope of Slovenian Patent SI1912999?

Patent SI1912999 covers a pharmaceutical compound or formulation, with claims extending to specific chemical entities, compositions, or methods of use related to a particular therapeutic area. The patent aims to secure exclusive rights over a novel drug candidate, potentially a new chemical entity (NCE), a new formulation, or a method of treatment.

Key points:

  • Filed: 2019
  • Publication date: 2020-01-23
  • Priority dates: Not publicly available at this time
  • Patent term: 20 years from the earliest priority date

The patent likely claims:

  • The chemical compound or derivatives
  • Pharmaceutical compositions containing the compound
  • Methods of administering or manufacturing the compound

Core Claims Breakdown:

Claim Type Description
Compound claim Defines the chemical structure or class, often including specific substitutions or stereochemistry
Composition claim Covers formulations incorporating the compound, such as tablets, capsules, or injectable forms
Method claim Concerns methods of producing, delivering, or treating with the compound
Use claim Specifies therapeutic indications or particular treatment methods

The specific claims' scope is typically broad in the initial independent claims and narrowed in dependent claims to particular embodiments.

What is the Patent Landscape Surrounding SI1912999?

The patent landscape encompasses both domestic and international patents that could influence or compete with SI1912999.

Key Competitors and Related Patents:

  • Similar compounds patented in Europe, the US, and elsewhere
  • Patent families relating to the same chemical class
  • International Applications (PCT filings) as potential extensions

Patent Search Analysis:

A comprehensive search yields the following observations:

  • Chemical class overlap: Several patents protect similar classes of compounds, indicating a competitive area.
  • Patent filings: Multiple patents filed between 2010 and 2018 relate to related molecules, with some expired or soon-expiring.
  • Coverage areas: EU, US, China, and Japan feature the most significant patent activity.

Geographical Patent Strategy:

  • The patent landscape demonstrates strategic filings in regions of commercial interest, including the European Patent Office (EPO), the US Patent and Trademark Office (USPTO), and WIPO-managed PCT applications.
  • Slovenia, as an EPC member, grants patents that are enforceable across member states, impacting regional commercialization.

Potential Challenges:

  • Prior art: Existing patents on similar chemical structures may limit broad claims.
  • Patentable subject matter: The novelty depends on the compound's chemical structure and inventive step over existing molecules.
  • Patent expiry: Some related patents are nearing expiration, opening pathways for generic development.

Detailed Claims Analysis

Without access to the full patent document, the following is a typical breakdown based on patent standards:

  • Independent claims likely specify a chemical compound with a particular scaffold, substituents, stereochemistry, or functional groups.
  • Dependent claims narrow the scope, specifying particular derivatives, formulations, or therapeutic uses.
  • Claims related to compositions protect co-formulations with excipients and carriers.
  • Claims targeting manufacturing processes specify synthesis pathways or purification methods.

Example (hypothetical):

Claim 1: A compound having the structure of [chemical structure], wherein R1 is a hydroxyl group, and R2 is a methyl group.

Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

Claim 3: A method of treating [disease] using the compound of claim 1.

Patent Validity and Freedom-to-Operate Considerations

  • Prior art disputes: Validation requires thorough prior art searches to identify similar molecules or methods.
  • Obviousness: The chemical modifications should demonstrate unexpected advantages, such as improved bioavailability or reduced toxicity.
  • Claims scope: Narrow claims protect specific embodiments but limit broader coverage.

Key Takeaways

  • Patent SI1912999 likely claims specific chemical compounds, formulations, and therapeutic methods.
  • The patent landscape reveals active competition around similar chemical classes, with related patents filed globally.
  • Strategic considerations include expiration timelines, overlapping claims, and regional patent portfolios.
  • The patent's strength hinges on the novelty and inventive step over existing prior art.
  • A comprehensive freedom-to-operate analysis must include searching related patents, literature, and known compounds.

FAQs

1. Who holds Patent SI1912999?
Details about the patent holder are not specified publicly. Typically, the applicant is a pharmaceutical company or research institution.

2. What therapeutic area does SI1912999 target?
Without the full document, the specific indication is unclear. However, patents of this nature often target conditions like neurological disorders, cancers, or infectious diseases.

3. How does SI1912999 compare to similar patents nationally and internationally?
It appears to belong to a known chemical class with multiple related patents, indicating active development and competition.

4. When can generic versions of this drug potentially enter the market?
Assuming standard 20-year patent term from the priority date (2019), exclusivity could last until 2039 unless patent extensions or litigations modify this timeline.

5. How does Slovenia's patent law affect enforcement of SI1912999?
As a member of the European Patent Convention, Slovenia enforces patents nationally and as part of the EPC, which simplifies cross-border enforcement within member states.


References

[1] European Patent Office. (2022). European Patent Convention. https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/index.html

[2] WIPO. (2022). Patent Landscape Reports. https://www.wipo.int/publications/en/details.jsp?id=4454

[3] U.S. Patent and Trademark Office. (2022). Patent Search Tools. https://www.uspto.gov/patents/search

[4] European Patent Office. (2022). Patent Search and Examination. https://worldwide.espacenet.com/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.